![Human Complement C6 Antibody Conjugated to Biotin](/proxy_img/aHR0cHM6Ly9tb2xlY3VsYXJkZXBvdC5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMjMvMTEvQjIwMTQ3MjEucG5n.png)
![All Products](/proxy_img/aHR0cHM6Ly9tb2xlY3VsYXJkZXBvdC5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTkvMDUvQWxsUHJvZHVjdHMtNjAweDUwOS5wbmc=.png)
Human Complement C6 Antibody Conjugated to Biotin
Catalog Number: B2014721 (50 ug)
Human Complement C6 Antibody Conjugated to Biotin is a high quality Human Complement C6 Antibody Conjugated to Biotin. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Live enquiry about this product via Text/SMS: 1-858-900-3210.
Product Description
Human Complement C6 Antibody Conjugated to Biotin
Catalog number: B2014721
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 ug
Molecular Weight or Concentration: N/A
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: -20°C
Keywords: Human Complement Monoclonal Antibody (Biotin Conjugate)
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Falk RJ, Dalmasso AP, Kim Y, Tsai CH, Scheinman JI, Gewurz H, Michael AF. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease J Clin Invest. 1983 Aug;72(2):560-73.
2: Mollnes TE, Lea T, Frøland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex Scand J Immunol. 1985 Aug;22(2):197-202.
3: Zilberman-Itskovich S, Abu-Hamad R, Stark M, Efrati S. Effect of anti-C5 antibody on recuperation from ischemia/reperfusion-induced acute kidney injury Ren Fail. 2019 Nov;41(1):967-975.
4: Mollnes TE, Lea T, Harboe M, Tschopp J. Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma Scand J Immunol. 1985 Aug;22(2):183-95.
5: Würzner R, Orren A, Potter P, Morgan BP, Ponard D, Späth P, Brai M, Schulze M, Happe L, Götze O. Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals Clin Exp Immunol. 1991 Mar;83(3):430-7.
6: Biesecker G, Wagner JL, Hugli TE. The release of C5a in complement-activated serum does not require C6 J Immunol. 1989 Aug 15;143(4):1228-32.
7: Lopes dos Santos M, Yeda FP, Tsuruta LR, Horta BB, Pimenta AA Jr, Degaki TL, Soares IC, Tuma MC, Okamoto OK, Alves VA, Old LJ, Ritter G, Moro AM. Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer PLoS One. 2013 Jul 31;8(7):e70332.
8: Sorkin LS, Otto M, Baldwin WM 3rd, Vail E, Gillies SD, Handgretinger R, Barfield RC, Yu HM, Yu AL. Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia Pain. 2010 Apr;149(1):135-142.
9: Rother RP, Squinto SP, Mason JM, Rollins SA. Protection of retroviral vector particles in human blood through complement inhibition Hum Gene Ther. 1995 Apr;6(4):429-35.
10: Johnson RJ. Involvement of complement components in renal disease Curr Opin Nephrol Hypertens. 1997 Mar;6(2):120-7.
Products Related to Human Complement C6 Antibody Conjugated to Biotin can be found at Antibodies
Additional Information
Weight | 0.15 oz |
---|---|
Dimensions | 2 × 0.5 × 0.5 in |